Invizyne Technologies Common Stock Probability Of Bankruptcy

IZTC Stock   15.61  0.23  1.45%   
Invizyne Technologies' odds of distress is under 9% at the present time. It has tiny probability of undergoing some form of financial hardship in the near future. Probability of distress shows the probability of financial torment over the next two years of operations under current economic and market conditions. All items used in analyzing the odds of distress are taken from the Invizyne balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Invizyne Technologies Piotroski F Score and Invizyne Technologies Altman Z Score analysis.
  

Invizyne Technologies Common Company probability of distress Analysis

Invizyne Technologies' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Invizyne Technologies Probability Of Bankruptcy

    
  Less than 9%  
Most of Invizyne Technologies' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Invizyne Technologies Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Invizyne Technologies probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Invizyne Technologies odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Invizyne Technologies Common financial health.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Invizyne Technologies. If investors know Invizyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Invizyne Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Invizyne Technologies is measured differently than its book value, which is the value of Invizyne that is recorded on the company's balance sheet. Investors also form their own opinion of Invizyne Technologies' value that differs from its market value or its book value, called intrinsic value, which is Invizyne Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invizyne Technologies' market value can be influenced by many factors that don't directly affect Invizyne Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invizyne Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Invizyne Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invizyne Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Invizyne Technologies Common has a Probability Of Bankruptcy of 9.0%. This is 79.21% lower than that of the Healthcare sector and 83.59% lower than that of the Biotechnology industry. The probability of bankruptcy for all United States stocks is 77.4% higher than that of the company.

Invizyne Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Invizyne Technologies' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Invizyne Technologies could also be used in its relative valuation, which is a method of valuing Invizyne Technologies by comparing valuation metrics of similar companies.
Invizyne Technologies is currently under evaluation in probability of bankruptcy category among its peers.

About Invizyne Technologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Invizyne Technologies Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Invizyne Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Invizyne Technologies Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Invizyne Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Invizyne Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Invizyne Technologies Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Invizyne Technologies Common Stock:
Check out Invizyne Technologies Piotroski F Score and Invizyne Technologies Altman Z Score analysis.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Invizyne Technologies. If investors know Invizyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Invizyne Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Invizyne Technologies is measured differently than its book value, which is the value of Invizyne that is recorded on the company's balance sheet. Investors also form their own opinion of Invizyne Technologies' value that differs from its market value or its book value, called intrinsic value, which is Invizyne Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invizyne Technologies' market value can be influenced by many factors that don't directly affect Invizyne Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invizyne Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Invizyne Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invizyne Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.